Effect of matcha green tea on cognitive functions and sleep quality in older adults with cognitive decline: A randomized controlled study over 12 months.

Autor: Kazuhiko Uchida, Kohji Meno, Tatsumi Korenaga, Shan Liu, Hideaki Suzuki, Yoshitake Baba, Chika Tagata, Yoshiharu Araki, Shuto Tsunemi, Kenta Aso, Shun Inagaki, Sae Nakagawa, Makoto Kobayashi, Tatsuyuki Kakuma, Takashi Asada, Miho Ota, Takanobu Takihara, Tetsuaki Arai

Publikováno v: PLoS ONE, Vol 19, Iss 8, p e0309287 (2024)

ObjectiveLifestyle habits after middle age significantly impact the maintenance of cognitive function in older adults. Nutritional intake is closely related to lifestyle habits; therefore, nutrition is a pivotal factor in the prevention of dementia i

Externí odkaz: https://doaj.org/article/37f8d2f620fc456b918dd167874d67dd

Serum levels of proteins involved in amyloid‐β clearance are related to cognitive decline and neuroimaging changes in mild cognitive impairment

Autor: Shan Liu, Hideaki Suzuki, Hitomi Ito, Tatsumi Korenaga, Hiroyasu Akatsu, Kohji Meno, Kazuhiko Uchida

Publikováno v: Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 11, Iss 1, Pp 85-97 (2019)

Abstract Introduction Amyloid‐β (Aβ) clearance is important for damage prevention in Alzheimer's disease. We investigated the utility of Aβ clearance proteins as biomarkers for mild cognitive impairment (MCI). Methods Serum apolipoprotein (apo)

Externí odkaz: https://doaj.org/article/d57ded684cb548769d78c5c261d9ee31

Amyloid‐β sequester proteins as blood‐based biomarkers of cognitive decline

Autor: Kazuhiko Uchida, Liu Shan, Hideaki Suzuki, Yo Tabuse, Yoshinori Nishimura, Yoshihiro Hirokawa, Katsuyoshi Mizukami, Hiroyasu Akatsu, Kohji Meno, Takashi Asada

Publikováno v: Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 1, Iss 2, Pp 270-280 (2015)

Abstract Introduction There are no blood‐based biomarkers for cognitive decline in aging, or mild cognitive impairment (MCI) and Alzheimer's disease (AD). Cumulative evidence suggests that apolipoproteins, complement system, and transthyretin are i

Externí odkaz: https://doaj.org/article/97ef5e3cfd6844a88100ee159d021500

Structural brain network correlations with amyloid burden in elderly individuals at risk of Alzheimer's disease

Autor: Hideaki Suzuki, Kazuhiko Uchida, Yuriko Numata, Eriko Tsukada, Miho Ota, Tetsuaki Arai, Kohji Meno, Ayako Kitabatake, Tomohiro Kaneta, Tatsumi Korenaga, Takashi Asada

Publikováno v: Psychiatry Research: Neuroimaging. 319:111415

Alzheimer's disease (AD) has a long preclinical phase during which beta-amyloid accumulates in the brain without cognitive impairment. However, the pattern of brain network alterations in this early stage of the disease remains to be clarified. In th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18724294854a4f16fded1495862ae890
https://doi.org/10.1016/j.pscychresns.2021.111415

Serum levels of proteins involved in amyloid-β clearance are related to cognitive decline and neuroimaging changes in mild cognitive impairment

Autor: Tatsumi Korenaga, Shan Liu, Hideaki Suzuki, Kohji Meno, Kazuhiko Uchida, Hiroyasu Akatsu, Hitomi Ito

Publikováno v: Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 11, Iss 1, Pp 85-97 (2019)

Introduction Amyloid-β (Aβ) clearance is important for damage prevention in Alzheimer's disease. We investigated the utility of Aβ clearance proteins as biomarkers for mild cognitive impairment (MCI). Methods Serum apolipoprotein (apo) A-I, compli

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e11f36ca8f99b7645a47240dcddeb70
https://pubmed.ncbi.nlm.nih.gov/30671532